• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Worldwide incidence of cervical lesions: a systematic review.全球宫颈病变发病率:一项系统综述。
Epidemiol Infect. 2015 Jan;143(2):225-41. doi: 10.1017/S0950268814001356. Epub 2014 May 30.
2
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
3
Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.非洲宫颈细胞学正常和肿瘤形成的女性中人类乳头瘤病毒基因型的流行情况:一项系统综述和荟萃分析
PLoS One. 2015 Apr 14;10(4):e0122488. doi: 10.1371/journal.pone.0122488. eCollection 2015.
4
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].[卫生技术评估报告。液基细胞学在宫颈癌前病变筛查中的应用]
Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33.
5
Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.女性人乳头瘤病毒感染及疾病的预防性疫苗接种:随机对照试验的系统评价
CMAJ. 2007 Aug 28;177(5):469-79. doi: 10.1503/cmaj.070948. Epub 2007 Aug 1.
6
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.人乳头瘤病毒检测与重复细胞学检查用于轻度宫颈细胞学病变的分流
Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD008054. doi: 10.1002/14651858.CD008054.pub2.
7
Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.葡萄牙 2/3 级宫颈上皮内瘤变和宫颈癌中人类乳头瘤病毒型别分布:CLEOPATRE II 研究。
Int J Gynecol Cancer. 2013 Mar;23(3):500-6. doi: 10.1097/IGC.0b013e318280f26e.
8
Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.在未进行人乳头瘤病毒(HPV)检测的情况下,对于轻度宫颈细胞学异常,立即转诊至阴道镜检查与细胞学监测的比较
Cochrane Database Syst Rev. 2017 Jan 26;1(1):CD009836. doi: 10.1002/14651858.CD009836.pub2.
9
Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.抗逆转录病毒疗法与人类免疫缺陷病毒感染者的高危型人乳头瘤病毒、宫颈上皮内瘤变和浸润性宫颈癌的关系:系统评价和荟萃分析。
Lancet HIV. 2018 Jan;5(1):e45-e58. doi: 10.1016/S2352-3018(17)30149-2. Epub 2017 Oct 26.
10
Specific human papillomavirus types and other factors on the risk of cervical intraepithelial neoplasia: a case-control study in Korea.特定型别的人乳头瘤病毒与其他因素对宫颈上皮内瘤变风险的影响:韩国的一项病例对照研究。
Int J Gynecol Cancer. 2010 Aug;20(6):1067-73. doi: 10.1111/IGC.0b013e3181e4a720.

引用本文的文献

1
Addressing the burden of cervical cancer for Indigenous women in Latin America and the Caribbean: a call for action.解决拉丁美洲和加勒比地区土著妇女的宫颈癌负担:行动呼吁。
Front Public Health. 2024 May 14;12:1376748. doi: 10.3389/fpubh.2024.1376748. eCollection 2024.
2
Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions.基于免疫的生物标志物可准确预测咪喹莫特免疫疗法治疗宫颈高级别鳞状上皮内病变的反应。
J Immunother Cancer. 2022 Nov;10(11). doi: 10.1136/jitc-2022-005288.
3
Factors associated with timely colposcopy following an abnormal cervical cancer test result.与宫颈癌检查结果异常后及时行阴道镜检查相关的因素。
Prev Med. 2022 Nov;164:107307. doi: 10.1016/j.ypmed.2022.107307. Epub 2022 Oct 18.
4
Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol.拉美地区人乳头瘤病毒检测用于宫颈癌筛查的多中心研究及分流方法评估:ESTAMPA 筛查研究方案。
BMJ Open. 2020 May 24;10(5):e035796. doi: 10.1136/bmjopen-2019-035796.
5
Clinical, laboratory and epidemiological aspects of HPV infection in a low-income population from South Bahia, Brazil.巴西巴伊亚州南部低收入人群中HPV感染的临床、实验室及流行病学特征
Epidemiol Infect. 2017 Dec;145(16):3398-3404. doi: 10.1017/S0950268817002448. Epub 2017 Nov 23.
6
The Mouse Papillomavirus Infection Model.小鼠乳头瘤病毒感染模型。
Viruses. 2017 Aug 30;9(9):246. doi: 10.3390/v9090246.
7
Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits.VX2荷瘤兔腹膜后淋巴结中肿瘤诱导的VEGF-C过表达
Drug Des Devel Ther. 2015 Nov 5;9:5949-56. doi: 10.2147/DDDT.S89810. eCollection 2015.
8
Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas.重编程能量代谢并诱导血管生成:宫颈癌中一元羧酸转运蛋白与VEGF家族成员的共表达
BMC Cancer. 2015 Nov 2;15:835. doi: 10.1186/s12885-015-1842-4.
9
Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.在小鼠乳头瘤病毒感染模型中追踪阴道、肛门和口腔感染情况。
J Gen Virol. 2015 Dec;96(12):3554-3565. doi: 10.1099/jgv.0.000295.
10
Frequency of Human Papilloma Virus (HPV) subtypes 31,33,35,39 and 45 among Yemeni women with cervical cancer.也门宫颈癌女性中人乳头瘤病毒(HPV)31、33、35、39和45亚型的感染频率
Infect Agent Cancer. 2015 Sep 7;10:29. doi: 10.1186/s13027-015-0026-9. eCollection 2015.

本文引用的文献

1
Early detection of CIN3 and cervical cancer during long-term follow-up using HPV/Pap smear co-testing and risk-adapted follow-up in a locally organised screening programme.在本地组织的筛查项目中,使用 HPV/Pap 联合检测和风险适应随访对 CIN3 和宫颈癌进行长期随访的早期检测。
Int J Cancer. 2014 Sep 15;135(6):1408-16. doi: 10.1002/ijc.28783. Epub 2014 Feb 27.
2
High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.巴氏涂片阴性时伴有和不伴有宫颈管成分的高级别宫颈异常和宫颈癌:10 年随访的队列研究。
Int J Cancer. 2014 Sep 1;135(5):1213-9. doi: 10.1002/ijc.28756. Epub 2014 Mar 13.
3
High-risk and low-risk human papillomavirus and the absolute risk of cervical intraepithelial neoplasia or cancer.高危型和低危型人乳头瘤病毒与宫颈上皮内瘤变或癌症的绝对风险。
Obstet Gynecol. 2014 Jan;123(1):57-64. doi: 10.1097/AOG.0000000000000056.
4
Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial.HPV 阴性女性保护作用的长期持续时间:原发性 HPV 筛查随机对照试验的随访。
BMJ. 2014 Jan 16;348:g130. doi: 10.1136/bmj.g130.
5
The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States.特定型别人乳头瘤病毒感染对宫颈癌前病变和癌症检出的影响:美国机会性宫颈筛查的基于人群研究。
Int J Cancer. 2014 Aug 1;135(3):624-34. doi: 10.1002/ijc.28605. Epub 2014 Apr 15.
6
Annual Papanicolaou screening for 5 years among human papillomavirus-negative women.5 年内对人乳头瘤病毒阴性女性进行年度巴氏涂片筛查。
BMC Cancer. 2013 Aug 9;13:379. doi: 10.1186/1471-2407-13-379.
7
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years.指导 21 至 24 岁女性管理的 5 年 CIN3+风险。
J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S64-8. doi: 10.1097/LGT.0b013e3182854399.
8
Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive.HPV 阳性但巴氏涂片阴性女性的 CIN3+和宫颈癌 5 年风险。
J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S56-63. doi: 10.1097/LGT.0b013e318285437b.
9
Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women.近期和既往性伴侣对人乳头瘤病毒感染的影响:老年女性的新发感染和再激活。
Cancer Res. 2012 Dec 1;72(23):6183-90. doi: 10.1158/0008-5472.CAN-12-2635. Epub 2012 Sep 27.
10
Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis.全球女性持续性生殖器人乳头瘤病毒感染模式:文献回顾和荟萃分析。
Int J Cancer. 2013 Sep 15;133(6):1271-85. doi: 10.1002/ijc.27828. Epub 2012 Oct 11.

全球宫颈病变发病率:一项系统综述。

Worldwide incidence of cervical lesions: a systematic review.

作者信息

Ting J, Rositch A F, Taylor S M, Rahangdale L, Soeters H M, Sun X, Smith J S

机构信息

Department of Clinical Pharmacy,University of California,San Francisco, CA,USA.

Department of Epidemiology,Johns Hopkins Bloomberg School of Public Health,Baltimore, MD,USA.

出版信息

Epidemiol Infect. 2015 Jan;143(2):225-41. doi: 10.1017/S0950268814001356. Epub 2014 May 30.

DOI:10.1017/S0950268814001356
PMID:24877975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9206785/
Abstract

We conducted a systematic review summarizing data on incidence of high- and low-grade lesions in women with normal baseline cervical cytology, stratified by age (<30 and ⩾30 years), and baseline human papillomavirus (HPV) infection. Incidence of high- and low-grade lesions in women aged ⩾30 years with a baseline HPV infection increased over follow-up time (5-127 months), although incidence generally remained <10%. Without baseline HPV infection, incidence of high-grade lesions remained low over follow-up time (<5% over 5-122 months). Incidence of high-grade lesions in women aged ⩾30 years with baseline HPV infection appeared similar to that in women aged <30 years. In some women aged <30 years, high-grade lesions can develop relatively shortly after initial HPV infection. We observed an increase in low-grade lesions over time in women aged ⩾30 years with baseline HPV infection, potentially indicative of an HPV infection that is potentially progressing to higher grade lesions.

摘要

我们进行了一项系统综述,总结了基线宫颈细胞学检查正常的女性中高级别和低级别病变的发生率数据,并按年龄(<30岁和⩾30岁)以及基线人乳头瘤病毒(HPV)感染情况进行分层。在随访时间(5 - 127个月)内,基线HPV感染的30岁及以上女性中高级别和低级别病变的发生率有所增加,尽管发生率总体仍<10%。在无基线HPV感染的情况下,高级别病变的发生率在随访期间保持较低水平(5 - 122个月内<5%)。基线HPV感染的30岁及以上女性中高级别病变的发生率似乎与<30岁女性相似。在一些<30岁的女性中,高级别病变可能在初次HPV感染后相对较短的时间内发生。我们观察到基线HPV感染的30岁及以上女性中低级别病变随时间增加,这可能表明HPV感染有进展为更高级别病变的潜在趋势。